| Michael Blaine Lenhart, MD | |
|
228 West 4th St, Suite 200, Cookeville, TN 38501 | |
| (931) 372-0405 | |
| (931) 372-0463 |
| Full Name | Michael Blaine Lenhart |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 228 West 4th St, Cookeville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053427187 | NPI | - | NPPES |
| 3091395 | Medicaid | TN | |
| 4288920 | Other | TN | BCBS |
| 64929425 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD26635 (Tennessee) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 0101044023 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Tappahannock Hospital | Tappahannock, VA | Hospital |
| Medical College Of Virginia Hospitals | Richmond, VA | Hospital |
| Community Memorial Hospital | South hill, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cmh Physician Services Llc | 3779551445 | 108 |
| Mcv Associated Physicians | 4385542117 | 1312 |
News Archive
Today AIDS Healthcare Foundation, in response to recent press reports regarding drug manufacturer Gilead Sciences, Inc.'s new four-drug HIV/AIDS pill, known as the "Quad," renewed its call for company to price the drug reasonably, particularly in light of the fact that it represents only a marginal improvement over existing medications.
Aided by ultrasound guidance, treating tumors with extreme heat or moderate heat may provide a possible therapeutic option, according to early research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held March 7-10, 2010.
More young people of all ages are surviving cancer than ever before, but new research published today in The Lancet Oncology journal shows that adolescents and young adults have a lower chance of surviving eight relatively common types of cancer than children, according to the latest data from a long-running study of cancer survival across Europe.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has been awarded two new patents in Japan and Ukraine.
› Verified 2 days ago
| Entity Name | Mcv Associated Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710959457 PECOS PAC ID: 4385542117 Enrollment ID: O20031230000559 |
News Archive
Today AIDS Healthcare Foundation, in response to recent press reports regarding drug manufacturer Gilead Sciences, Inc.'s new four-drug HIV/AIDS pill, known as the "Quad," renewed its call for company to price the drug reasonably, particularly in light of the fact that it represents only a marginal improvement over existing medications.
Aided by ultrasound guidance, treating tumors with extreme heat or moderate heat may provide a possible therapeutic option, according to early research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held March 7-10, 2010.
More young people of all ages are surviving cancer than ever before, but new research published today in The Lancet Oncology journal shows that adolescents and young adults have a lower chance of surviving eight relatively common types of cancer than children, according to the latest data from a long-running study of cancer survival across Europe.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has been awarded two new patents in Japan and Ukraine.
› Verified 2 days ago
| Entity Name | Blue Ridge Medical Management Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326159567 PECOS PAC ID: 9739099441 Enrollment ID: O20040715001336 |
News Archive
Today AIDS Healthcare Foundation, in response to recent press reports regarding drug manufacturer Gilead Sciences, Inc.'s new four-drug HIV/AIDS pill, known as the "Quad," renewed its call for company to price the drug reasonably, particularly in light of the fact that it represents only a marginal improvement over existing medications.
Aided by ultrasound guidance, treating tumors with extreme heat or moderate heat may provide a possible therapeutic option, according to early research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held March 7-10, 2010.
More young people of all ages are surviving cancer than ever before, but new research published today in The Lancet Oncology journal shows that adolescents and young adults have a lower chance of surviving eight relatively common types of cancer than children, according to the latest data from a long-running study of cancer survival across Europe.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has been awarded two new patents in Japan and Ukraine.
› Verified 2 days ago
| Entity Name | Cmh Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194760645 PECOS PAC ID: 3779551445 Enrollment ID: O20040921000171 |
News Archive
Today AIDS Healthcare Foundation, in response to recent press reports regarding drug manufacturer Gilead Sciences, Inc.'s new four-drug HIV/AIDS pill, known as the "Quad," renewed its call for company to price the drug reasonably, particularly in light of the fact that it represents only a marginal improvement over existing medications.
Aided by ultrasound guidance, treating tumors with extreme heat or moderate heat may provide a possible therapeutic option, according to early research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held March 7-10, 2010.
More young people of all ages are surviving cancer than ever before, but new research published today in The Lancet Oncology journal shows that adolescents and young adults have a lower chance of surviving eight relatively common types of cancer than children, according to the latest data from a long-running study of cancer survival across Europe.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has been awarded two new patents in Japan and Ukraine.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Blaine Lenhart, MD 228 West 4th St, Suite 200, Cookeville, TN 38501-2489 Ph: (931) 372-0405 | Michael Blaine Lenhart, MD 228 West 4th St, Suite 200, Cookeville, TN 38501 Ph: (931) 372-0405 |
News Archive
Today AIDS Healthcare Foundation, in response to recent press reports regarding drug manufacturer Gilead Sciences, Inc.'s new four-drug HIV/AIDS pill, known as the "Quad," renewed its call for company to price the drug reasonably, particularly in light of the fact that it represents only a marginal improvement over existing medications.
Aided by ultrasound guidance, treating tumors with extreme heat or moderate heat may provide a possible therapeutic option, according to early research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held March 7-10, 2010.
More young people of all ages are surviving cancer than ever before, but new research published today in The Lancet Oncology journal shows that adolescents and young adults have a lower chance of surviving eight relatively common types of cancer than children, according to the latest data from a long-running study of cancer survival across Europe.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has been awarded two new patents in Japan and Ukraine.
› Verified 2 days ago
Scott F Reising, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 228 W. 4th Street, Suite 200, Cookeville, TN 38501 Phone: 931-372-0405 Fax: 931-372-0463 | |
Stacy David Brewington, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 228 W. 4th Street, Suite 200, Cookeville, TN 38501 Phone: 931-372-0405 Fax: 931-372-0463 | |
Mark Arden Pierce, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 145 W 4th St, Suite 201, Cookeville, TN 38501 Phone: 931-783-2902 Fax: 931-783-2219 | |
Dr. Toney Britton Hudson, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 315 N Washington Ave, Ste 165, Cookeville, TN 38501 Phone: 931-526-1604 Fax: 931-526-7378 | |
James Chike Ezi-ashi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 438 N Whitney Ave, Cookeville, TN 38501 Phone: 931-783-2616 Fax: 931-783-2610 | |
Dr. Brian Keith Dockery, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 228 W 4th St, Suite 200, Cookeville, TN 38501 Phone: 931-372-0405 Fax: 931-372-0463 |